A QUARTER-CENTURY OF ANTIVIRAL THERAPY

被引：4

作者：

MERIGAN, TC

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1995年 / 333卷 / 25期

关键词：

D O I：

10.1056/NEJM199512213332509

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1704 / 1705

页数：2

共 24 条

[1]

COLLIER AC, 1995, 35 INT C ANT AG CHEM, P236

[2] A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE [J].

DANNER, SA ;

CARR, A ;

LEONARD, JM ;

LEHMAN, LM ;

GUDIOL, F ;

GONZALES, J ;

RAVENTOS, A ;

RUBIO, R ;

BOUZA, E ;

PINTADO, V ;

AGUADO, AG ;

DELOMAS, JG ;

DELGADO, R ;

BORLEFFS, JCC ;

HSU, A ;

VALDES, JM ;

BOUCHER, CAB ;

COOPER, DA ;

GIMENO, C ;

CLOTET, B ;

TOR, J ;

FERRER, E ;

MARTINEZ, PL ;

MORENO, S ;

ZANCADA, G ;

ALCAMI, J ;

NORIEGA, AR ;

PULIDO, F ;

GLASSMAN, HN .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1528-1533

[3] A PRELIMINARY TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS-B INFECTION [J].

DIENSTAG, JL ;

PERRILLO, RP ;

SCHIFF, ER ;

BARTHOLOMEW, M ;

VICARY, C ;

RUBIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1657-1661

[4] INVITRO RESISTANCE TO ZIDOVUDINE AND ALPHA-INTERFERON IN HIV-1 ISOLATES FROM PATIENTS - CORRELATIONS WITH TREATMENT DURATION AND RESPONSE [J].

EDLIN, BR ;

STCLAIR, MH ;

PITHA, PM ;

WHALING, SM ;

KING, DM ;

BITRAN, JD ;

WEINSTEIN, RA .

ANNALS OF INTERNAL MEDICINE, 1992, 117 (06) :457-460

[5] TREATMENT WITH LAMIVUDINE, ZIDOVUDINE, OR BOTH IN HIV-POSITIVE PATIENTS WITH 200 TO 500 CD4+ CELLS PER CUBIC MILLIMETER [J].

ERON, JJ ;

BENOIT, SL ;

JEMSEK, J ;

MACARTHUR, RD ;

SANTANA, J ;

QUINN, JB ;

KURITZKES, DR ;

FALLON, MA ;

RUBIN, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1662-1669

[6]

GALASSO GJ, 1990, ANTIVIRAL AGENTS VIR

[7] EFFECT OF HUMAN LEUKOCYTE INTERFERON ON HEPATITIS B VIRUS-INFECTION IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS [J].

GREENBERG, HB ;

POLLARD, RB ;

LUTWICK, LI ;

GREGORY, PB ;

ROBINSON, WS ;

MERIGAN, TC .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (10) :517-522

[8]

HAMMER S, 1995, 35TH INT C ANT AG CH, P8

[9] PREEMPTIVE GANCICLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN CYTOMEGALOVIRUS ANTIBODY-POSITIVE RENAL-TRANSPLANT RECIPIENTS - A RANDOMIZED CONTROLLED TRIAL [J].

HIBBERD, PL ;

TOLKOFFRUBIN, NE ;

CONTI, D ;

STUART, F ;

THISTLETHWAITE, JR ;

NEYLAN, JF ;

SNYDMAN, DR ;

FREEMAN, R ;

LORBER, MI ;

RUBIN, RH .

ANNALS OF INTERNAL MEDICINE, 1995, 123 (01) :18-26

[10]

KATLAMA C, 1995, 2 NAT C HUM RETR REL, P29

← 1 2 3 →